Human Tau (MAPT) activation kit by CRISPRa
CAT#: GA102816
MAPT CRISPRa kit - CRISPR gene activation of human microtubule associated protein tau
Find the corresponding CRISPRi Inhibitor Kit
USD 1,290.00
2 Weeks*
Specifications
Product Data | |
Format | 3gRNAs, 1 scramble ctrl and 1 enhancer vector |
Symbol | MAPT |
Locus ID | 4137 |
Kit Components | GA102816G1, Tau gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA102816G2, Tau gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA102816G3, Tau gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Disclaimer | The kit is designed based on the best knowledge of CRISPa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc. |
Reference Data | |
RefSeq | NM_001123066, NM_001123067, NM_001203251, NM_001203252, NM_005910, NM_016834, NM_016835, NM_016841, NM_173727 |
Synonyms | DDPAC; FTDP-17; MAPTL; MSTD; MTBT1; MTBT2; PPND; PPP1R103; TAU |
Summary | 'This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]' |
Documents
Product Manuals |
FAQs |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN213312 | MAPT - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN213312BN | MAPT - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN213312LP | MAPT - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN213312RB | MAPT - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN413312 | MAPT - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
USD 1,290.00 |
{0} Product Review(s)
Be the first one to submit a review